Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Active rabies vaccine (US-FDA approved)
Active rabies vaccine · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| KamRAB | EXPERIMENTAL | KamRAB 20 IU/kg body weight via IM injection, once on Day 0 |
| FDA approved HRIG product | ACTIVE_COMPARATOR | Comparator product: Intramuscular (IM) injection once on Day 0 in the same manner and at the same dosage as KamRAB. |
| Name | Type | Description |
|---|---|---|
| Active rabies vaccine (US-FDA approved) | DRUG | A 1.0 ml dose of active vaccine (2.5 IU/ml), will be given on 5 occasions, on Days 0, 3, 7, 14, and 28 On day 0, the day when the HRIG is given, the first vaccine dose could be given within few minutes from the time of HRIG injection was given and never be administered into the same anatomical site as the HRIG. |
Inclusion Criteria: * Able and willing to sign an informed consent. * Healthy male or female subjects of 18 - 75 years of age inclusive who have not previously been immunized against rabies. * Ability to comply with completion of a home diary. * No previous exposure to Rabies epidemic, Rabies vacci...
The Active rabies vaccine is used for rabies, an infectious disease. It is being developed by Kamada Ltd. as a vaccine candidate. The vaccine is intended to induce an active immune response against rabies, and it has been studied in healthy adult subjects in the United States.
The Active rabies vaccine is developed by Kamada Ltd., which trades under the ticker KMDA. Kamada is the company responsible for the clinical development of this vaccine candidate for rabies.
The Active rabies vaccine is in Phase 2 development. It has completed one clinical trial, a Phase II/III study, and is not currently listed as having any active trials. It is an investigational vaccine and is not approved by the FDA.
The Active rabies vaccine has been studied in one completed clinical trial, NCT02040090. This was a Phase II/III randomized, double-blind, active-controlled study of the safety and effectiveness of HRIG with active rabies vaccine in healthy subjects. It enrolled 118 participants in the United States.
Yes, the Active rabies vaccine is also known as Active rabies vaccine (US-FDA approved). This alternative name refers to the same vaccine candidate developed by Kamada Ltd. for rabies.